HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1

BACKGROUND: Activating EGFR mutations, HER2, and HER3 are implicated in lung cancer; however, with the exception of EGFR gene amplification in lung adenocarcinoma harboring EGFR mutations, their involvement in disease progression during the early stages is poorly understood. In this paper, we focuse...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumagai, Toru, Tomita, Yasuhiko, Nakatsuka, Shin‐ichi, Kimura, Madoka, Kunimasa, Kei, Inoue, Takako, Tamiya, Motohiro, Nishino, Kazumi, Susaki, Yoshiyuki, Kusu, Takashi, Tokunaga, Toshiteru, Okami, Jiro, Higashiyama, Masahiko, Imamura, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879050/
https://www.ncbi.nlm.nih.gov/pubmed/29473311
http://dx.doi.org/10.1111/1759-7714.12609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879050/
https://www.ncbi.nlm.nih.gov/pubmed/29473311
http://dx.doi.org/10.1111/1759-7714.12609

Ejemplares similares